Nobuo Cho

1.7k citations

28 papers · 1.4k · h-index 18

Impact in

Hematology top 5%
- Multiple Myeloma Research and Treatments
Molecular Biology top 10%
- Protein Degradation and Inhibitors
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research

Papers in

Molecular Biology 24
- Protein Degradation and Inhibitors 12
- Ubiquitin and proteasome pathways 6
- Cancer therapeutics and mechanisms 3
- RNA Interference and Gene Delivery 2
Organic Chemistry 4
- Synthesis and Reactivity of Heterocycles 2

Co-authors: Norihito Shibata (9 shared papers)Hiroshi Nara (9 shared papers)Mikihiko Naito (10 shared papers)Takayuki Hattori (8 shared papers)Nobumichi Ohoka (8 shared papers)Osamu Ujikawa (6 shared papers)Tomoya Sameshima (7 shared papers)Kenichiro Shimokawa (7 shared papers)
Journals: Journal of Medicinal Chemistry (7 papers)Bioorganic & Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Chemical and Pharmaceutical Bulletin (2 papers)Cancer Science (2 papers)
Partner nations: Japan United States China

In The Last Decade

Nobuo Cho

26 papers receiving 1.4k citations

Peers

Countries citing papers authored by Nobuo Cho

Since Specialization

Citations

This map shows the geographic impact of Nobuo Cho's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Cho with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Cho more than expected).

Fields of papers citing papers by Nobuo Cho

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nobuo Cho. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Cho. The network helps show where Nobuo Cho may publish in the future.

Co-authors

The 25 scholars most cited alongside Nobuo Cho, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nobuo Cho Line = papers co-authored together Nobuo Cho links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs) Journal of Biological Chemistry ·Nobumichi Ohoka, Keiichiro Okuhira, Masahiro Ito, Katsunori Nagai, Norihito Shibata, Takayuki Hattori, Osamu Ujikawa, Kenichiro Shimokawa, Osamu Sano, Ryokichi Koyama, Hisashi Fujita, Mika Teratani, Hirokazu Matsumoto, Yasuhiro Imaeda, Hiroshi Nara, Nobuo Cho, Mikihiko Naito	2017	201
2	Discovery of a Thieno[2,3- d ]pyrimidine-2,4-dione Bearing a p -Methoxyureidophenyl Moiety at the 6-Position: A Highly Potent and Orally Bioavailable Non-Peptide Antagonist for the Human Luteinizing Hormone-Releasing Hormone Receptor Journal of Medicinal Chemistry ·Satoshi Sasaki, Nobuo Cho, Yoshi Nara, Masataka Harada, Satoshi Endo, Nobuhiro Suzuki, Shuichi Furuya, Masahiko Fujino	2002	146
3	Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands Journal of Medicinal Chemistry ·Norihito Shibata, Katsunori Nagai, Yoko Morita, Osamu Ujikawa, Nobumichi Ohoka, Takayuki Hattori, Ryokichi Koyama, Osamu Sano, Yasuhiro Imaeda, Hiroshi Nara, Nobuo Cho, Mikihiko Naito	2017	124
4	Discovery of a Novel, Potent, and Orally Active Nonpeptide Antagonist of the Human Luteinizing Hormone-Releasing Hormone (LHRH) Receptor Journal of Medicinal Chemistry ·Nobuo Cho, Masataka Harada, Toshihiro Imaeda, Takashi Imada, Hirokazu Matsumoto, Yoji Hayase, Satoshi Sasaki, Shuichi Furuya, Nobuhiro Suzuki, Shoichi Okubo, Kazuhiro Ogi, Satoshi Endo, Haruo Onda, Masahiko Fujino	1998	113
5	K-Ras(G12D)-selective inhibitory peptides generated by random peptide T7 phage display technology Biochemical and Biophysical Research Communications ·Kotaro Sakamoto, Yusuke Kamada, Tomoya Sameshima, Masahiro Yaguchi, Ayumu Niida, Shigekazu Sasaki, Masanori Miwa, Shoichi Ohkubo, Junichi Sakamoto, Masahiro Kamaura, Nobuo Cho, Akiyoshi Tani	2017	94
6	Discovery of Potent Mcl-1/Bcl-xL Dual Inhibitors by Using a Hybridization Strategy Based on Structural Analysis of Target Proteins Journal of Medicinal Chemistry ·Yuta Tanaka, Katsuji Aikawa, Goushi Nishida, Misaki Homma, Satoshi Sogabe, S. Igaki, Yumi Hayano, Tomoya Sameshima, Ikuo Miyahisa, Tomohiro Kawamoto, Michiko Tawada, Yumi Imai, Masakazu Inazuka, Nobuo Cho, Yasuhiro Imaeda, Tomoyasu Ishikawa	2013	93
7	Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation ACS Medicinal Chemistry Letters ·Kenichiro Shimokawa, Norihito Shibata, Tomoya Sameshima, Naoki Miyamoto, Osamu Ujikawa, Hiroshi Nara, Nobumichi Ohoka, Takayuki Hattori, Nobuo Cho, Mikihiko Naito	2017	91
8	Development of protein degradation inducers of oncogenic BCR‐ABL protein by conjugation of ABL kinase inhibitors and IAP ligands Cancer Science ·Norihito Shibata, Naoki Miyamoto, Katsunori Nagai, Kenichiro Shimokawa, Tomoya Sameshima, Nobumichi Ohoka, Takayuki Hattori, Yasuhiro Imaeda, Hiroshi Nara, Nobuo Cho, Mikihiko Naito	2017	90
9	Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor α degradation Journal of Biological Chemistry ·Nobumichi Ohoka, Yoko Morita, Katsunori Nagai, Kenichiro Shimokawa, Osamu Ujikawa, Ikuo Fujimori, Masahiro Ito, Youji Hayase, Keiichiro Okuhira, Norihito Shibata, Takayuki Hattori, Tomoya Sameshima, Osamu Sano, Ryokichi Koyama, Yasuhiro Imaeda, Hiroshi Nara, Nobuo Cho, Mikihiko Naito	2018	87
10	Peroxisome Proliferator-Activated Receptor γ Agonists as Insulin Sensitizers: From the Discovery to Recent Progress Current Topics in Medicinal Chemistry ·Nobuo Cho, Yū Momose	2008	70
11	Different Degradation Mechanisms of Inhibitor of Apoptosis Proteins (IAPs) by the Specific and Nongenetic IAP-Dependent Protein Eraser (SNIPER) Chemical and Pharmaceutical Bulletin ·Nobumichi Ohoka, Osamu Ujikawa, Kenichiro Shimokawa, Tomoya Sameshima, Norihito Shibata, Takayuki Hattori, Hiroshi Nara, Nobuo Cho, Mikihiko Naito	2018	48
12	Pharmacological difference between degrader and inhibitor against oncogenic BCR-ABL kinase Scientific Reports ·Norihito Shibata, Kenichiro Shimokawa, Katsunori Nagai, Nobumichi Ohoka, Takayuki Hattori, Naoki Miyamoto, Osamu Ujikawa, Tomoya Sameshima, Hiroshi Nara, Nobuo Cho, Mikihiko Naito	2018	46
13	SNIPER(TACC3) induces cytoplasmic vacuolization and sensitizes cancer cells to Bortezomib Cancer Science ·Nobumichi Ohoka, Katsunori Nagai, Norihito Shibata, Takayuki Hattori, Hiroshi Nara, Nobuo Cho, Mikihiko Naito	2017	34
14	Suppression of a Pituitary-Ovarian Axis by Chronic Oral Administration of a Novel Nonpeptide Gonadotropin-Releasing Hormone Antagonist, TAK-013, in Cynomolgus Monkeys The Journal of Clinical Endocrinology & Metabolism ·Takahito Hara, Hideo Araki, Masami Kusaka, Masataka Harada, Nobuo Cho, Nobuhiro Suzuki, Shuichi Furuya, Masahiko Fujino	2003	28
15	Second-Generation AUTACs for Targeted Autophagic Degradation Journal of Medicinal Chemistry ·Daiki Takahashi, Taiichi Ora, Shigekazu Sasaki, Naoki Ishii, Toshio Tanaka, Takumi Matsuda, Mutsuki Ikeda, Jun Moriyama, Nobuo Cho, Hiroshi Nara, Hironobu Maezaki, Masahiro Kamaura, Kenichiro Shimokawa, Hirokazu Arimoto	2023	24
16	A new class of potent nonpeptide luteinizing hormone-releasing hormone (LHRH) antagonists: design and synthesis of 2-phenylimidazo[1,2-a]pyrimidin-5-ones Bioorganic & Medicinal Chemistry Letters ·Satoshi Sasaki, Toshihiro Imaeda, Yoji Hayase, Yoshiaki Shimizu, Shizuo Kasai, Nobuo Cho, Masataka Harada, Nobuhiro Suzuki, Shuichi Furuya, Masahiko Fujino	2002	22
17	Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent Journal of Medicinal Chemistry ·Osamu Kurasawa, T. Miyazaki, Misaki Homma, Yuya Oguro, Takashi Imada, Noriko Uchiyama, Kenichi Iwai, Yukiko Yamamoto, Momoko Ohori, Hideto Hara, Hiroshi Sugimoto, Kentaro Iwata, R.J. Skene, Isaac Hoffman, Akihiro Ohashi, Toshiyuki Nomura, Nobuo Cho	2020	19
18	Design, Synthesis, and Structure−Activity Relationships of Thieno[2,3-b]pyridin-4-one Derivatives as a Novel Class of Potent, Orally Active, Non-Peptide Luteinizing Hormone-Releasing Hormone Receptor Antagonists Journal of Medicinal Chemistry ·Takashi Imada, Nobuo Cho, Toshihiro Imaeda, Yoji Hayase, Satoshi Sasaki, Shizuo Kasai, Masataka Harada, Hirokazu Matsumoto, Satoshi Endo, Nobuhiro Suzuki, Shuichi Furuya	2006	18
19	Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones Bioorganic & Medicinal Chemistry ·Osamu Kurasawa, Yuya Oguro, T. Miyazaki, Misaki Homma, Kouji Mori, Kenichi Iwai, Hideto Hara, R.J. Skene, Isaac Hoffman, Akihiro Ohashi, Sei Yoshida, Tomoyasu Ishikawa, Nobuo Cho	2017	15
20	2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase Bioorganic & Medicinal Chemistry ·Osamu Kurasawa, Misaki Homma, Yuya Oguro, T. Miyazaki, Kouji Mori, Noriko Uchiyama, Kenichi Iwai, Akihiro Ohashi, Hideto Hara, Sei Yoshida, Nobuo Cho	2017	12

About Nobuo Cho

Nobuo Cho is a scholar working on Molecular Biology, Organic Chemistry, Oncology, Reproductive Medicine and Hematology, having authored 28 papers that have together received 1.4k indexed citations. Recurring topics across this work include Protein Degradation and Inhibitors (12 papers), Ubiquitin and proteasome pathways (6 papers), Hypothalamic control of reproductive hormones (4 papers), CAR-T cell therapy research (3 papers), Cancer therapeutics and mechanisms (3 papers), RNA Interference and Gene Delivery (2 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Synthesis and Reactivity of Heterocycles (2 papers). The work is most often cited by research in Hematology (282 citations), Molecular Biology (1.0k citations), Reproductive Medicine (118 citations), Oncology (348 citations) and Organic Chemistry (222 citations). Nobuo Cho has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Norihito Shibata, Hiroshi Nara, Mikihiko Naito, Takayuki Hattori, Nobumichi Ohoka, Osamu Ujikawa, Tomoya Sameshima, Kenichiro Shimokawa, Katsunori Nagai and Yasuhiro Imaeda. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Chemical and Pharmaceutical Bulletin and Cancer Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Nobuo Cho

Impact in

Papers in i

In The Last Decade

Nobuo Cho

Peers

Countries citing papers authored by Nobuo Cho

Fields of papers citing papers by Nobuo Cho

All Works

About Nobuo Cho

Explore authors with similar magnitude of impact

Papers in